MCE 的所有產(chǎn)品僅用作科學(xué)研究，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

CAS No. : 105628-07-7

MCE 國際站：Fasudil Hydrochloride

產(chǎn)品活性：Fasudil Hydrochloride (HA-1077 Hydrochloride; AT877 Hydrochloride) 是一種非特異性 ROCK 抑制劑，對蛋白激酶也有抑制作用，ROCK1 的 K_i 值為 0.33 μM，ROCK2 和 PKA，PKC，PKG 的 IC₅₀ 值分別 0.158 μM 和 4.58 μM，12.30 μM，1.650 μM。Fasudil Hydrochloride 也是一種有效的 Ca²⁺ 通道拮抗劑和血管擴(kuò)張劑。

研究領(lǐng)域：Cell Cycle/DNA Damage  |  Stem Cell/Wnt  |  Cytoskeleton  |  TGF-beta/Smad  |  Neuronal Signaling  |  Membrane Transporter/Ion Channel  |  Autophagy  |  Protein Tyrosine Kinase/RTK  |  Epigenetics  |  Anti-infection

作用靶點(diǎn)：ROCK  |  Calcium Channel  |  Autophagy  |  PKA  |  PKC  |  HIV

In Vitro: Fasudil Hydrochloride (100 μM) inhibits cell spreading, the formation of stress fibers, and expression of α-SMA with concomitant suppression of cell growth in rat HSCs and human HSC-derived TWNT-4 cells.
Fasudil Hydrochloride (50-100 μM; 24 hours) inhibits the LPA-induced phosphorylation of ERK1/2, JNK, and p38 detected by western blotting in rat HSCs and human HSC-derived TWNT-4 cells.
Fasudil Hydrochloride (25-100 μM; 24 hours) suppresses transcription of collagen and TIMP, stimulates transcription of MMP-1 in human HSC-derived TWNT-4 cells.

In Vivo: Fasudil (30 μg) increases CBF by 50% via intra-coronary injection to dogs. Fasudil (0.01, 0.03, 0.1 and 0.3 mg/kg, bolus, i.v.) decreases MBP and increases HR, VBF, CBF, RBF, and FBF. Fasudil (1.0 ng/mL) increases cardiac output. Fasudil via i.v. produces a significant fall in MBP, left ventricular systolic pressure and total peripheral resistance with an increase in HR and cardiac output, but without obvious effect on right atrial pressure, dP/dt or left ventricular minute work in dogs. Fasudil exhibits protectable effects on cardiovascular disease and reduces the activation of JNK and attenuates mitochondrial-nuclear translocation of AIF under ischemic injury. Fasudil (100 mg/kg/day, p.o.) significantly reduces incidence and mean maximum clinical score of EAE in SJL/J mice immunized with PLP p139-151. Fasudil inhibits the proliferative response of splenocytes to the antigen in mice. Fasudil decreases inflammation, demyelination, axonal loss and APP positivein spinal cord of Fasudil-treated mice via p.o. administration.

相關(guān)產(chǎn)品：FDA-Approved Drug Library Plus  |  Drug Repurposing Compound Library  |  Anti-Infection Compound Library  |  Reprogramming Compound Library  |  FDA-Approved Drug Library Mini  |  Anti-Aging Compound Library  |  Kinase Inhibitor Library  |  Neuronal Signaling Compound Library  |  Anti-Virus Compound Library  |  Oxygen Sensing Compound Library  |  Anti-COVID-19 Compound Library  |  Stem Cell Signaling Compound Library  |  FDA-Approved Drug Library  |  Protein Tyrosine Kinase Compound Library  |  Anti-Cancer Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  Drug Repurposing Compound Library Plus  |  Epigenetics Compound Library  |  NMPA-Approved Drug Library  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Autophagy Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  TGF-beta/Smad Compound Library  |  Doxorubicin hydrochloride  |  Phorbol 12-myristate 13-acetate  |  Chloroquine phosphate  |  Y-27632 dihydrochloride  |  Staurosporine  |  5-Fluorouracil  |  Panobinostat  |  Q-VD-OPh  |  H-89 dihydrochloride  |  Midostaurin  |  (-)-Epigallocatechin Gallate  |  Valproic acid  |  Plerixafor  |  Birinapant  |  Neomycin sulfate  |  Ionomycin  |  Go 6983  |  Thapsigargin  |  Verapamil hydrochloride  |  Bucladesine sodium  |  Flavopiridol  |  Shikonin  |  Nifedipine  |  Dolutegravir  |  Chroman 1  |  Mitoxantrone  |  Probenecid  |  Ritonavir  |  Maraviroc

品牌介紹:
•   MCE (MedChemExpress) 擁有數(shù)百種全球獨(dú)家化合物，我們致力于為全球科研客戶提供最新最全的高品質(zhì)小分子活性化合物；
•   10,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域；
•   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證；
•   Nature, Cell, Science 等多種頂級(jí)期刊及制藥專利收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球最新的活性化合物；
•   與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長期的合作。